“Analysis of The Relationship Between Polypharmacy and Potentially Inappropriate Medications (PIMs) Based on The 2023 Beers Criteria in Geriatric Diabetes Mellitus Patients ” (2026) Duta Pharma Journal, 6(1), pp. 64–77. doi:10.47701/pqjb4t96.